These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7698695)

  • 1. Wheat deficient in gliadins: promising tool for treatment of coeliac disease.
    Frisoni M; Corazza GR; Lafiandra D; De Ambrogio E; Filipponi C; Bonvicini F; Borasio E; Porceddu E; Gasbarrini G
    Gut; 1995 Mar; 36(3):375-8. PubMed ID: 7698695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children.
    Auricchio S; De Ritis G; De Vincenzi M; Occorsio P; Silano V
    Pediatr Res; 1982 Dec; 16(12):1004-10. PubMed ID: 7155669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of different wheat gliadins in coeliac disease.
    Wieser H; Springer G; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1982; 175(5):321-6. PubMed ID: 6758408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins.
    Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS
    Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of monococcum wheat in celiac patients.
    Gianfrani C; Maglio M; Rotondi Aufiero V; Camarca A; Vocca I; Iaquinto G; Giardullo N; Pogna N; Troncone R; Auricchio S; Mazzarella G
    Am J Clin Nutr; 2012 Dec; 96(6):1339-45. PubMed ID: 23134879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between gliadin structure and coeliac toxicity.
    Wieser H
    Acta Paediatr Suppl; 1996 May; 412():3-9. PubMed ID: 8783747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spelt wheat and celiac disease].
    Forssell F; Wieser H
    Z Lebensm Unters Forsch; 1995 Jul; 201(1):35-9. PubMed ID: 7571865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.
    Pizzuti D; Buda A; D'Odorico A; D'Incà R; Chiarelli S; Curioni A; Martines D
    Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a gluten free product containing wheat gliadin in patients with coeliac disease.
    Ciclitira PJ; Ellis HJ; Fagg NL
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):83. PubMed ID: 6428688
    [No Abstract]   [Full Text] [Related]  

  • 10. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.
    De Angelis M; Rizzello CG; Fasano A; Clemente MG; De Simone C; Silano M; De Vincenzi M; Losito I; Gobbetti M
    Biochim Biophys Acta; 2006 Jan; 1762(1):80-93. PubMed ID: 16311022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and molecular characterization of bread wheat lines with reduced amount of α-type gliadins.
    Camerlengo F; Sestili F; Silvestri M; Colaprico G; Margiotta B; Ruggeri R; Lupi R; Masci S; Lafiandra D
    BMC Plant Biol; 2017 Dec; 17(1):248. PubMed ID: 29258439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention by a decapeptide from durum wheat of in vitro gliadin peptide-induced apoptosis in small-bowel mucosa from coeliac patients.
    Silano M; Leonardi F; Trecca A; Mancini E; Di Benedetto R; De Vincenzi M
    Scand J Gastroenterol; 2007 Jun; 42(6):786-7. PubMed ID: 17506006
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis.
    Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F
    Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The toxicity of certain cereal proteins in coeliac disease.
    Cornell HJ; Townley RR
    Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
    Cornell HJ; Maxwell RJ
    Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of the techique of organ culture for studying gluten toxicity in coeliac disease.
    Hauri HP; Kedinger M; Haffen K; Gaze H; Hadorn B; Hekkens W
    Gut; 1978 Dec; 19(12):1090-8. PubMed ID: 744495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of food processing and simulated gastrointestinal digestion on gliadin immunoreactivity in rolls.
    Brzozowski B
    J Sci Food Agric; 2018 Jul; 98(9):3363-3375. PubMed ID: 29277903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The precipitating factor in coeliac disease.
    Wieser H
    Baillieres Clin Gastroenterol; 1995 Jun; 9(2):191-207. PubMed ID: 7549024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and functional properties of wheat gliadins: a review.
    Barak S; Mudgil D; Khatkar BS
    Crit Rev Food Sci Nutr; 2015; 55(3):357-68. PubMed ID: 24915383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of prolamins by RNAi in bread wheat: effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins.
    Barro F; Iehisa JC; Giménez MJ; García-Molina MD; Ozuna CV; Comino I; Sousa C; Gil-Humanes J
    Plant Biotechnol J; 2016 Mar; 14(3):986-96. PubMed ID: 26300126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.